FLN29, a Novel Interferon- and LPS-inducible Gene Acting as a Negative Regulator of Toll-like Receptor Signaling
Ryuichi Mashima(Tokyo Medical and Dental University), Akihiko Yoshimura(Kyushu University)
Cited by 65
Related Papers
A novel cytokine‐inducible gene CIS encodes an SH2‐containing protein that binds to tyrosine‐phosphorylated interleukin 3 and erythropoietin receptors.
|The EMBO Journal|1995|758
Cellular and molecular basis for the regulation of inflammation by TGF-
|The Journal of Biochemistry|2010|386
Smad2 and Smad3 Are Redundantly Essential for the TGF-β–Mediated Regulation of Regulatory T Plasticity and Th1 Development
|The Journal of Immunology|2010|323
Notch-mediated conversion of activated T cells into stem cell memory-like T cells for adoptive immunotherapy
|Nature Communications|2017|99
FLN29 Deficiency Reveals Its Negative Regulatory Role in the Toll-like Receptor (TLR) and Retinoic Acid-inducible Gene I (RIG-I)-like Helicase Signaling Pathway
|Journal of Biological Chemistry|2008|66